hemangiol
pierre fabre medicament - propranololhydrochlorid - hemangioma - betablokkende midler - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.
propal retard 160 mg depotkapsler, hårde
sandoz a/s - propranololhydrochlorid - depotkapsler, hårde - 160 mg
propal retard 80 mg depotkapsler, hårde
sandoz a/s - propranololhydrochlorid - depotkapsler, hårde - 80 mg
tenidon mite 50 + 12,5 mg filmovertrukne tabletter
viatris limited - atenolol, chlortalidon - filmovertrukne tabletter - 50 + 12,5 mg
tenoretic mite 50+12,5 mg filmovertrukne tabletter
pfizer aps - atenolol, chlortalidon - filmovertrukne tabletter - 50+12,5 mg
tenormin 100 mg filmovertrukne tabletter
pfizer aps - atenolol - filmovertrukne tabletter - 100 mg
tenormin 25 mg filmovertrukne tabletter
pfizer aps - atenolol - filmovertrukne tabletter - 25 mg
tenormin 50 mg filmovertrukne tabletter
pfizer aps - atenolol - filmovertrukne tabletter - 50 mg
uniloc 100 mg tabletter
takeda pharma a/s - atenolol - tabletter - 100 mg
uniloc 25 mg tabletter
takeda pharma a/s - atenolol - tabletter - 25 mg